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Abstract
Ovarian hormones increase breast cancer risk by poorly under-
stood mechanisms. We assess the role of progesterone on global
stem cell function by serially transplanting mouse mammary
epithelia. Progesterone receptor (PR) deletion severely reduces the
regeneration capacity of the mammary epithelium. The PR target,
receptor activator of Nf-jB ligand (RANKL), is not required for this
function, and the deletion of Wnt4 reduces the mammary regener-
ation capacity even more than PR ablation. A fluorescent reporter
reveals so far undetected perinatal Wnt4 expression that is inde-
pendent of hormone signaling. Pubertal and adult Wnt4 expression
is specific to PR+ luminal cells and requires intact PR signaling.
Conditional deletion of Wnt4 reveals that this early, previously
unappreciated, Wnt4 expression is functionally important. We
provide genetic evidence that canonical Wnt signaling in the
myoepithelium required PR and Wnt4, whereas the canonical Wnt
signaling activities observed in the embryonic mammary bud and
in the stroma around terminal end buds are independent of Wnt4.
Thus, progesterone and Wnt4 control stem cell function through a
luminal–myoepithelial crosstalk with Wnt4 acting independent of
PR perinatally.
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Introduction
The two key ovarian hormones, 17-b-estradiol (E2) and progester-
one, regulate postnatal mammary gland development but also
promote carcinogenesis in this organ. They act via nuclear recep-
tors, the estrogen receptor a (ER) and the progesterone receptor
(PR), respectively, which are expressed in between 30 and 50% of
the mammary epithelial cells in the inner, luminal layer (Clarke
et al, 1997). It was proposed that they impinge on ER-/PR-negative
mammary stem cells by paracrine mechanisms (Tanos & Brisken,
2008). Experimental evidence for this model was provided with
fluorescence-activated cell sorting (FACS)-based approaches
(Asselin-Labat et al, 2010; Joshi et al, 2010). The single-cell-based
methods have been used to characterize mammary epithelial cell
populations and to establish a cellular hierarchy within the
mammary epithelium. Among dissociated CD24+ mouse mammary
epithelial cells, the cell populations with high surface expression of
integrin b1 (CD29hi) or integrin a6 (CD49fhi) were enriched for cells
with the ability to establish new milk ducts in mammary fat pads
surgically cleared of their endogenous epithelium and were hence
considered bipotent mammary stem cells able to give rise to both
luminal and basal/myoepithelial cell lineage (Shackleton et al,
2006; Stingl et al, 2006). These cells express basal/myoepithelial
markers such as cytokeratin 5 and 14, smooth muscle actin, and
laminin (Shackleton et al, 2006; Stingl et al, 2006) and their
numbers increase during pregnancy and after stimulation with E2
and progesterone (Asselin-Labat et al, 2010; Joshi et al, 2010) and
decrease upon ovariectomy or anti-estrogen treatment (Asselin-
Labat et al, 2010).
However, the physiological relevance of the dramatic expansion
of these bipotent stem cells in response to hormones (Asselin-Labat
et al, 2010; Joshi et al, 2010) is questioned by lineage-tracing exper-
iments showing that postnatal mammary gland development is
largely driven by luminal and basal/myoepithelial lineage-restricted
stem cells (Taddei et al, 2008; Zeng & Nusse, 2010; Van Keymeulen
et al, 2011; Rios et al, 2014). The lineage-restricted stem cells are
not amenable to study by the single stem cell assays where the
normal stem cell niche and its microenvironment are disrupted.
Recurrent peaks in serum progesterone levels are linked to
menstrual cycles which are an important risk factor for breast carci-
nogenesis (Brisken, 2013). Moreover, most cell proliferation occurs
in the luminal compartment and breast cancers arise from luminal
and/or luminal progenitor cells (Molyneux et al, 2010). This begs
the question how important progesterone is to mammary stem cell
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function in the intact tissue context and through which signaling
pathways it impinges on different types of mammary stem cells, that
is, bipotential, luminal restricted, and basal restricted.
Mammary epithelium was shown to serially engraft cleared
mammary fat pads for up to seven cycles (Daniel, 1973). This assay,
which is based on the engraftment of an intact piece of mammary
epithelium, preserves the epithelial architecture with its associated
extracellular matrix, fibroblasts, and immune cells. It is currently
the only way to assay comprehensively the mammary regeneration
potential reflective of multiple types of stem and progenitor cells.
We combine this assay with different genetic mutant strain to define
the relative contributions of progesterone signaling and its down-
stream mediators RANKL and Wnt4 to the regenerative potential of
the mammary epithelium.
Results
PR signaling for mammary epithelial self-renewal
To assess the role of PR signaling in mammary stem cell control, we
serially engrafted pieces of intact mammary epithelium from the
PR/ and wild-type (WT) littermates into contralateral mammary
fat pads surgically cleared of their endogenous epithelium (Fig 1A).
This approach rather than injection of limiting dilutions of dissoci-
ated cell populations was chosen so that the physiological interac-
tions between the stem/progenitor cells and their microenvironment
in the mammary epithelium niche would be preserved and the func-
tion of all types of stem cells, the bipotential, the luminal-restricted,
and the basal-restricted stem cells, could be evaluated. To unequivo-
cally distinguish the engrafted cells from the endogenous epithelium
that may inadvertently be left after surgery, we used donors that
ubiquitously express the enhanced green fluorescent protein (EGFP)
(Okabe et al, 1997). To ensure that comparable amounts of mutant
(MT) and WT donor tissue with comparable amounts of epithelium
were engrafted, we dissected pinhead-sized fragments from the
inguinal glands near the lymph node on the side proximal to the
teat. Eight to 12 weeks after grafting, recipients were sacrificed and
the extent of outgrowth in the engrafted mammary glands was
determined. Pieces of mammary tissue resulting from the contralat-
eral PR/ and WT grafts were dissected and retransplanted
(Fig 1A). The WT epithelium completely reconstituted most of the
fat pads over 4 serial transplant cycles, as expected, but the PR/
epithelium ceased to reconstitute the mammary gland by the 3rd
cycle (Fig 1B, C, and H).
Paracrine mediators of PR signaling in mammary
epithelial self-renewal
The TNF-a family member, RANKL, was previously implicated in
the paracrine control of mammary stem cells by hormones on
the basis of use of dissociated individual stem cell assays
(Asselin-Labat et al, 2010). To determine the functional impor-
tance of RANKL in epithelial self-renewal, we serially engrafted
intact mammary epithelium derived from the RANKL/ and the
RANKL+/+ mice into cleared contralateral mammary fat pads. WT
epithelium fully reconstituted fat pads in most hosts over 4 serial
transplants and grew as expected (Fig 1D and E). Unexpectedly,
RANKL/ epithelia had the same regeneration capacity (Fig 1D
and E). The only significant difference was that the MT grafts
generated fewer side branches (Fig 1D and insets), consistent
with the reported proproliferative activity of RANKL and its role
in side branching (Beleut et al, 2010).
We tested the role of Wnt4 since evidence has accumulated
that Wnt signaling is important for mammary stem cell function
(Cai et al, 2014; Kessenbrock et al, 2013; Liu et al, 2004; van
Amerongen et al, 2012; Wang et al, 2014; Zeng & Nusse, 2010)
and Wnt4 is a key paracrine mediator of progesterone action
(Brisken et al, 2000). As Wnt4/ mice die at birth (Vainio et al,
1999), intact mammary epithelial buds from E12.5/E13.5 embryos
were used for the initial engraftment. It has been reported that
embryonic epithelia have more stem cells than postnatal epithelia
(Spike et al, 2012). Notwithstanding, we noticed that epithelial
tissue isolated from the Wnt4+/+ and the Wnt4+/ embryos recon-
stituted completely the mammary gland to the same extent as the
WT epithelia from postnatal mammary glands through three
transplantation cycles (Fig 1C, E, and G). However, the Wnt4/
epithelium only established 50% of the fat pad in the first cycle
and was reduced to 10% by the third cycle (Fig 1F and G). The
much more significant impairment of reconstitution capacity of
the Wnt4/ versus the PR/ grafts compared to their respective
contralateral controls (Fig 1H) points to a key role for Wnt4 in
the maintenance of the mammary stem cell function and indicates
that PR is not exclusively controlling Wnt4 expression. RANKL
▸Figure 1. PR, RANKL, and Wnt4 and their role in the regenerative capacity of the mammary gland.A Experimental scheme. Mammary tissue fragments dissected from wild-type (WT) or mutant (MT) donor mice were engrafted to contralateral mammary fat pads of
RAG1/ recipient mice surgically divested of the endogenous epithelium. Between 8 and 12 weeks later, the engrafted glands were assessed by fluorescent
stereomicroscopy and new fragments were dissected for serial engraftment.
B, C Serial transplantations of PR+/+ and PR/ mammary epithelia. (B) Fluorescence stereo micrographs of third-generation mammary outgrowths derived from
8-week-old PR+/+; EGFP and PR/; EGFP donor mice. (C) Table summarizing 3 independent serial transplant experiments with PR+/+; EGFP and PR/; EGFP. Each
engrafted gland is represented by a micrograph; black sectors represent area of fat pad filled by engrafted epithelium. Scale bar: 200 lm.
D, E Serial transplantation of RANKL+/+ and RANKL/ mammary epithelia. (D) Fluorescence stereo micrographs of third-generation mammary outgrowths derived from
5-week-old RANKL+/+; EGFP and RANKL/; EGFP donor mice. Insets: higher magnification showing side branches present in the WT control (arrowheads) absent
from RANKL/; EGFP epithelium. (E) Table summarizing three independent serial transplant experiments with RANKL+/+; EGFP and RANKL/; EGFP donor mice.
Scale bar: 200 lm.
F, G Serial transplantation of Wnt4+/+ and Wnt4/ mammary epithelia. (F) Fluorescence stereo micrographs of third-generation mammary outgrowths derived from
mammary buds of E12.5 and E13.5 Wnt4+/+; EGFP and Wnt4/; EGFP embryos. Scale bar: 200 lm. (G) Table summarizing three independent serial transplant
experiments with Wnt4+/+; EGFP donor mice. Scale bar: 200 lm.
H Box plot showing the difference between percentage of reconstitution between WT and MT contralateral grafts in each transplant generation. P values were
determined by Mann–Whitney U-test.
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does not appear to be essential in the control of the mammary
stem cells under physiological conditions.
Control of Wnt4 expression
Previous studies suggested that Wnt4 is expressed only concomitant
with high progesterone secretion in the adult and pregnant mammary
gland (Gavin & McMahon, 1992; Weber-Hall et al, 1994). The finding
that deletion of Wnt4 affected mammary regeneration potential more
severely than abrogation of PR signaling suggested that Wnt4 may
have PR-independent functions in stem cell stimulation. To detect
Wnt4 expression at low levels, we crossed mice which express Cre
from the Wnt4 locus (Wnt4::Cre) (Shan et al, 2009) to the mT/mG
dual Cre reporter strain in which ubiquitous tomato expression is
replaced by membrane EGFP upon Cre activation (Muzumdar et al,
2007). We failed to detect expression in embryos (E12.5 and E18.5)
and were unable to detect EGFP in the mammary glands of newborn
or 3-day-old double transgenic mice (Wnt4::GFP). EGFP expression
was detected on postnatal day 5 by fluorescence stereomicroscopy
(Fig 2A) prior to the onset of ovarian function. Immunofluorescence
of histological sections revealed EGFP expression in scattered
mammary epithelial cells on day 5 (Fig 2B) and day 10 (Fig 2C). PR
expression was not detected at these stages (Fig 2B and C). Consis-
tent with Wnt4 being a PR target, the double immunofluorescence for
histological sections from postnatal double transgenic mice (Wnt4::
EGFP) suggested that EGFP expression is restricted to PR+ luminal
cells in the glands of pubertal mice (Fig 2D), adult (Fig 2E and inset),
and pregnant females (Fig 2F and inset). To assess whether myoepi-
thelial cells may express EGFP, we performed triple immunofluores-
cence for EGFP, PR, and the myoepithelial marker p63. In mammary
epithelia from 5-day-old Wnt4::EGFP females (n = 7), rare double
positive cells were detected, and in most sections, cells expressed
either p63 or EGFP (Fig 2G). In 4- (Fig 2H) and 8-week-old (Fig 2I)
females, p63 and EGFP staining labeled distinct cells. Thus, Wnt4 is
expressed almost exclusively in luminal cells. The Wnt4 expressing
cells appear to be terminally differentiated as no clonal clusters of
EGFP+ cells are observed.
To assess whether trace amounts of estrogens and progesterone
of maternal origin could account for this perinatal Wnt4 expression,
we analyzed d15 mammary glands from the Wnt4::EGFP mice on
WT, ERa/, and PR/ genetic backgrounds by epifluorescence
stereomicroscopy. At this stage, ductal outgrowth was comparable
by red fluorescence (Fig 2J–L). Neither ERa nor PR deletion altered
Wnt4::EGFP expression (Fig 2M–O) indicating that perinatal Wnt4
expression is largely independent of ERa and PR signaling.
To determine the respective roles of the two major ovarian
hormones in control of Wnt4 expression, we pooled epithelial-
enriched organoids freshly isolated from mammary glands of puber-
tal and adult females (n = 3) and stimulated them for 6 h ex vivo
(Fig 2P) (Ayyanan et al, 2011). Progesterone induced Wnt4 mRNA
expression in pubertal and adult organoids to 8.7- and 4.5-fold,
respectively, whereas E2 elicited a 1.6-fold induction of Wnt4 mRNA
in the pubertal organoids only (Fig 2Q). To assess the physiological
importance of PR signaling for pubertal Wnt4 expression, we grafted
Wnt4::GFP epithelium derived from donors either PR/ or PRWT to
contralateral cleared fat pads of 3-week-old hosts. The engrafted
glands were analyzed 3 weeks later when the recipients were puber-
tal. Epifluorescence stereomicroscopy for dTomato revealing unre-
combined cells confirmed the presence of ductal outgrowth of
PRWT and PR/ grafts (Fig 2R and S). EGFP expression was readily
detected in the PRWT graft (Fig 2T) but completely absent from
some of the PR/ grafts (Fig 2U). Double epifluorescence stereo-
microscopy on a PRWT control graft reveals that EGFP is strongly
enriched in the TEBs (Fig 2V and X), and in the contralateral PR/
grafts, some EGFP expression is observed at the origin of the
outgrowth (Fig 2W). These findings are consistent with perinatal
ER-/PR-independent Wnt4 expression and indicate that pubertal
Wnt4 induction is mediated by PR signaling.
Consequences of Wnt4 ablation on cell proliferation
The observation that Wnt4 deletion impaired the regenerative
capacity of the mammary epithelium more severely than PR deletion
did, pointed to a role of Wnt4 before puberty. The fat pad grafting
approach used to determine Wnt4 function (Brisken et al, 2000)
assesses gene function from puberty onward because the donor
epithelium is placed into a 3-week-old host. To determine the role of
Wnt4 perinatally and at the onset of puberty, we conditionally
▸Figure 2. Control of Wnt4 expression.A Epifluorescence stereo micrograph of inguinal mammary gland from a 5-day-old Wnt4::Cre; mT/mG female (n = 7). Scale bars: 0.5 mm and 0.1 mm (inset).
B, C Histological sections of mammary glands from a 5-day-old (B; n = 7) and a 10-day-old (C; n = 5) Wnt4::Cre; mT/mG female stained by double immunofluorescence
for EGFP (green) and PR (magenta, not detected), counterstained with DAPI (blue). Scale bar: 50 mm.
D–F EGFP (green) and PR (magenta) co-immunofluorescence counterstained with DAPI (blue) on histological sections from mT/mG; Wnt4::Cre mammary glands at
different developmental stages. (D) TEB of a 4-week-old female (n = 4); scale bar: 30 lm. (E) Ducts of an 8-week-old female (n = 3); scale bar: 100 lm; inset, scale
bar: 20 lm. (F) Duct of a female at day 10.5 of pregnancy (n = 3); scale bar: 150 lm; inset, scale bar: 30 lm.
G–I EGFP (green), PR (magenta), and p63 (white) triple co-immunofluorescence counterstained with DAPI (blue) on histological sections from mT/mG; Wnt4::Cre
mammary glands at different developmental stages. (G) Ducts of 5-day-old female (n = 3). (H) TEB of a 4-week-old female (n = 3). (I) Duct of an 8-week-old female
(n = 3). Scale bars: 30 lm.
J–O Epifluorescence stereo micrographs of mammary glands harvested from 15-day-old Wnt4::GFP females either WT (n = 18) (J, M), ERa/ (n = 4) (K, N), or PR/
(n = 3) (L, O). dTomato expression (J–L); EGFP expression (M–O) is not abrogated in ERa/ nor PR/ epithelia. Arrowheads mark the main duct originating from
the nipple. Scale bar: 50 lm.
P Scheme of ex vivo hormone stimulation of mammary organoids.
Q Bar plots showing relative PR and Wnt4 mRNA expression normalized to CK18 mRNA in mammary organoids from 5 pubertal (6 weeks old) and 3 adult (11 weeks
old) mice exposed for 6 h to vehicle (C), 17b-estradiol (20 nmol) (E2), or R5020 (20 nmol) (P). Bars represent the mean  SD of 3 independent experiments.
R–X Epifluorescence stereo micrographs of contralateral mammary glands that were engrafted with Wnt4::GFP epithelium from 8-week-old females, either PRWT (R, T,
V, X) or PR/ (S, U, W). dTomato expression (R, S); EGFP expression (T, U) double epifluorescence (V, W, X) on contralateral engrafted glands 3 weeks after surgery
when recipients were 6 weeks old. Representative result from three independent experiments. Arrowheads point to TEBs (V, X) or to origin of growth (W). Scale bar
(R–W): 5 mm, (X): 1 mm.
The EMBO Journal Vol 34 | No 5 | 2015 ª 2015 The Authors
The EMBO Journal Progesterone/Wnt4 control of mammary stem cells Renuga Devi Rajaram et al
644
Published online: January 20, 2015 
HA day 5day 5 day 10
8 w 4 w d10.5 pregant
  WT                            ERα-/-                         PR-/-
d15 d15 d15
 
EG
FP
 
 
 
 
 
 
 
 
 
 
 
 
 
dT
o
m
a
to
harvest WT
mammary
glands
      fat
pellets enriched 
for epithelial cells
  C  E2  P          C  E2  P
RNA
mince
re
la
tiv
e 
m
R
N
A 
e
xp
re
ss
io
n
  p<0.0001
 p<0.05
 p<0.0001
    mince       hormone
        treatdigestion and
hormone treatmentment
Wnt4
B C
D E F
G I
J
DAPI
Wnt4::EGFP
p63
PR
8 w 
day 5
K L
M N O
P Q
R S
T U
  WT                  PR-/-
  WT  
  WT                  PR-/-
V
W
X
Figure 2.
ª 2015 The Authors The EMBO Journal Vol 34 | No 5 | 2015
Renuga Devi Rajaram et al Progesterone/Wnt4 control of mammary stem cells The EMBO Journal
645
Published online: January 20, 2015 
deleted Wnt4 in the mammary epithelium by crossing mice with
two conditional Wnt4 alleles (Wnt4fl/fl) (Shan et al, 2010) to mice
that express Cre in the mammary epithelium under the control of
the MMTV-LTR (A-strain) (Wagner et al, 2001). To identify cells
in which Cre-mediated recombination had occurred, the mice
were crossed to the mT/mG dual Cre reporter strain (Muzumdar
et al, 2007). Analysis of MMTV::Cre; mT/mG double transgenic
females revealed widespread EGFP expression at postnatal day 10
both by stereo microscopy and (Fig 3A–E) immunofluorescence
for EGFP (Fig 3F). In the Wnt4 depleted (MT) mammary glands,
a 10% decrease in the number of branching points was observed
compared to control littermates around day 10 (Fig 3G and H). In
pubertal MT glands, the number of terminal end buds (TEBs) had
decreased to 54% of the controls (Fig 3I and J). Similarly, the area of
fat pad filled by ducts was 60% of that measured in littermates
(Fig 3I and K). Cell proliferation, as assessed by BrdU incorporation,
was reduced to 65% of that in the WT counterparts in TEBs of Wnt4
mutants (Fig 3M). The proliferative index of about 6% in the
subtending ducts was not affected in the Wnt4-deficient glands
(Fig 3L). Thus, Wnt4 is required for perinatal and pubertal ductal
expansion.
Activation of myoepithelial cells through canonical Wnt signaling
Wnt4 can activate its signaling, both canonical and non-canonical
Wnt signaling (Lyons et al, 2004; Heinonen et al, 2011). Canonical
Wnt signaling activity can be assessed in vivo using the Axin2::LacZ
reporter mouse strain (Leung et al, 2002; Lustig et al, 2002) and
was reported in a subset of CD29fhi or CD49hi breast stem cells
Figure 3. Conditional deletion of Wnt4 in the mammary epithelium and
its consequences.
A–D Representative epifluorescence stereo micrographs of inguinal mammary
glands from a 10-day-old mT/mG (A, C) and MMTV::Cre; mT/mG (B, D)
female (n = 7). Scale bar: 1 mm.
E Higher magnification of inguinal mammary gland from a 10-day-old
MMTV::Cre; mT/mG female. Scale bar: 0.2 mm.
F Immunofluorescence for EGFP (green) on a mammary gland section
from a 10-day-old MMTV::Cre; mT/mG female counterstained with DAPI
(blue) (n = 7). Scale bar: 30 lm.
G Epifluorescence stereo micrographs of mammary glands from 10-day-
old littermates either MMTV::Cre; mT/mG Wnt4fl/+ or MMTV::Cre; mT/mG;
Wnt4fl/fl. Scale bar: 1 mm. Arrowhead marks the main duct originating
from the nipple.
H Bar plot showing ratio of branching points in prepubertal Cre+;Wnt4fl/fl
(n = 12) relative to Cre+;Wnt4fl/+ littermates (n = 10). Two-tailed, paired
Student’s t-test was used to calculate statistical significance.
I Fluorescence stereo micrographs of mammary glands from 35-day-old
littermates either MMTV::Cre; mT/m; Wnt4fl/+ or MMTV::Cre; mT/m;Wnt4fl/fl.
Note ductal elongation is delayed in Wnt4-deficient mammary
epithelium compared to Wnt4fl/+ control. LN: lymph node. Scale bar:
4 mm.
J, K Bar plots showing number of terminal end buds (TEBs) (J) and area of
mammary fat pad filled by the ductal system (K). Ctrl (Wnt4fl/wt or
Wnt4fl/fl; Cre): n = 6, fl/+; Cre+: n = 4, and fl/fl; Cre+: n = 7). Data are
presented as the mean  SD. Two-tailed Student’s t-test was used to
calculate statistical significance.
L, M Bar plots showing BrdU incorporation index in inguinal mammary
glands of 4-week-old Wnt4fl/+; Cre+ (n = 3) or Wnt4fl/fl; Cre+ (n = 4) in
the ducts (L) and in the TEBs (M). Data are presented as the mean  SD.
Two-tailed Student’s t-test was used to calculate statistical significance.
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Figure 4. Canonical Wnt signaling activity during mammary gland development.
A Whole-mount micrograph of X-gal-stained Axin2+/lacZ in E12.5 embryo showing b-galactosidase expression in the mammary buds (arrows) (n = 8). Scale bar:
1 mm. Arrowheads mark mammary buds.
B–F Whole-mount micrographs of X-gal (blue)- and carmine alum (red)-stained mammary glands harvested from Axin2+/lacZ mice at distinct developmental stages.
(B) At postnatal day 1, b-galactosidase activity detected in the nipple area (n = 6). Scale bar: 1 mm. (C, D) In 5-week-old mammary glands, reporter activity was
detected around the ducts (small arrows) and in the neck region of the terminal end buds (TEBs) (large arrows) (C) (n = 8). Scale bars: 400 lm (C) and 100 lm (D).
(E) At 8.5 day of pregnancy, reporter expression was detected in the ducts. Higher magnification (inset) suggests myoepithelial expression (n = 10). Scale bar:
1 mm. (F) Whole-mount at day 14.5 of pregnancy: reporter activity is limited to ducts (n = 5). Scale bar: 200 lm.
G Histological section of Axin2::LacZ mammary gland at day 8.5 of pregnancy counterstained with nuclear red; luminal epithelial cells show no detectable
b-galactosidase activity but myoepithelial cells do. Scale bar: 200 lm.
H b-galactosidase activity (blue) colocalizes with the myoepithelial marker p63 (green) detected by immunofluorescence. Arrows point to myoepithelial cells. L,
lumen. Scale bar: 100 lm.
I Representative whole-mount stereo micrographs of X-gal (blue)- and carmine alum (magenta)-stained mammary gland biopsies taken from 14-week-old
Axin2::LacZ females collected at diestrus and estrus, respectively (n = 3). Scale bar: 200 lm.
J Relative Wnt4 and Axin2 mRNA expression in mammary glands from three mice in estrus versus diestrus assessed by semiquantitative qRT–PCR normalized to
18S rRNA. Two-tailed, paired Student’s t-test was used to calculate statistical significance.
K Stereo micrographs of X-gal- and carmine alum-stained mammary glands from ovariectomized Axin2::LacZ females treated for 72 h with vehicle (n = 4) (left),
17-b-estradiol (E2) (n = 6) (center), 17-b-estradiol and progesterone (E2 and P) (n = 8) (right). Scale bar: 200 lm.
L, M Stereo micrographs of contralateral glands whole-mounted and X-gal stained after engraftment with mammary buds from Axin2::LacZ transgenic and Wnt4+/+ or
Wnt4/ female E12.5 and E13.5 embryos (L) or Axin2::LacZ transgenic and either PR+/ or PR/ 8-week-old females (M), at day 8.5 of pregnancy. b-galactosidase
expression reflecting Axin2 transcription is readily detected in PR+/ as well as Wnt4+/+ mammary epithelia but not in the PR/ (n = 6) and Wnt4/ counterparts
(n = 6). Blue: X-gal staining; magenta: carmine alum counterstain. Scale bars: 200 lm.
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(Zeng & Nusse, 2010; van Amerongen et al, 2012). We detected
reporter activity in the mammary buds of E12.5/13.5 embryos
(Fig 4A) consistent with previous reports based on an artificial Wnt
signaling reporter (Chu et al, 2004). Perinatal b-galactosidase activ-
ity was confined to the nipple area (Fig 4B). Importantly, during
puberty, LacZ expression was detected in the stroma surrounding
the TEB necks (Fig 4C and D). In adulthood, b-galactosidase activity
was readily detected in the ducts where it peaked on day 8.5 of preg-
nancy (Fig 4E). At day 14.5 of pregnancy, b-galactosidase activity
was still detected in the ducts but not in the newly formed alveoli
(Fig 4F). Histological sectioning suggested that X-gal staining
mapped to the myoepithelial layer (Fig 4G); immunostaining with
the myoepithelial marker p63 (Fig 4H) confirmed that LacZ is
exclusively expressed in myoepithelial cells. Thus, canonical Wnt
signaling in the postnatal mammary epithelium is confined to
myoepithelial cells.
The peak in myoepithelial b-galactosidase activity during mid-
pregnancy suggested that serum progesterone levels and hence
Wnt4 expression may control canonical Wnt signaling activation.
Indeed, when mammary glands in individual mice were analyzed,
during progesterone-low estrous, they had lower b-galactosidase
activity (Fig 4I) and lower Wnt4 and Axin2 mRNA levels than the
glands analyzed during progesterone-high diestrous (Fig 4J); the
fold differences varied between different animals (Fig 4I and J). To
assess whether PR signaling induces canonical Wnt signaling, ovari-
ectomized Axin2::LacZ females were treated with E2, to restore PR
expression, and progesterone. Axin2 transcription reflected by
b-galactosidase activity was induced by this combination but not by
solvent or E2 alone (Fig 4K). Thus, progesterone stimulation results
in increased transcription of Axin2, in the context of ER-dependent
PR induction.
Multiple Wnts, some of which are secreted by mammary stro-
mal cells, have been implicated in canonical Wnt signaling activa-
tion (Kessenbrock et al, 2013). To assess whether canonical Wnt
signaling requires Wnt4 expression, we generated Axin2::LacZ
transgenic mice in a Wnt4/ background. In females engrafted
with mammary buds from Axin2::LacZ+ female embryos, b-galac-
tosidase activity was readily detected in Wnt4+/+ grafts at preg-
nancy day 8.5 but abrogated in the contralateral Wnt4/
epithelia (Fig 4L). Similarly, it was decreased in PR+/ and abro-
gated in PR/ epithelia (Fig 4M), indicating that both PR and
Wnt4 are required for canonical Wnt signaling activation in the
myoepithelium.
Our finding that Wnt4 expression is detected only from postnatal
day 5 onward suggested that other family members, possibly
Wnt10b, might be responsible for canonical Wnt signaling activa-
tion in the embryonic mammary bud. In line with this scenario,
b-galactosidase activity was readily detected in the embryonic
mammary buds of Wnt4/::axin2::LacZ female E14.5 embryos
(Fig 5A). To test whether the stromal Axin2 expression around TEB
necks depends on epithelial Wnt4 expression, we generated
MMTV::Cre; axin2::LacZ females either Wnt4fl/fl or Wnt4fl/wt. Analy-
sis of their mammary glands during puberty (6 weeks) showed that
b-galactosidase activity was comparable between the two genotypes
(Fig 5B). Thus, canonical Wnt signaling activation in the mammary
bud and stroma is Wnt4 independent, whereas specifically in the
myoepithelium, canonical Wnt signaling activation requires epithe-
lial Wnt4 expression.
Discussion
Our data point to Wnt4 as a pivotal control factor of stem cell
function for postnatal mammary gland development. We have
uncovered a novel role for Wnt4 in perinatal development and
puberty with progesterone as its major endocrine control factor.
Progesterone, colloquially named ‘pregnancy hormone,’ appears
as a primordial systemic factor in the postnatal mammary gland.
It is the major proliferative stimulus to the adult mammary
epithelium (Beleut et al, 2010) and controls the regenerative
potential of the mammary gland by activating stem/progenitor
cells throughout hormone-dependent development. Surprisingly,
while hormone stimulation experiments had shown that estrogens
induce Wnt4 expression (Brisken et al, 2000; Cai et al, 2014), we
find that genetic deletion of PR signaling completely abrogated
Wnt4 expression during puberty. Yet, the two ovarian hormones
remain intertwined in Wnt4 control with ERa signaling acting
indirectly as an upstream regulator of PR expression (Haslam &
Shyamala, 1979) (Fig 6A).
We had previously analyzed Wnt4 function in the mammary
gland by grafting Wnt4/ embryonic buds to cleared fat pads of
pubertal mice and therefore failed to discern the prepubertal func-
tion of Wnt4 uncovered through the use of the conditional Wnt4
A
B
Figure 5. Wnt4-independent canonical Wnt signaling during mammary
gland development.
A X-gal-stained whole-mounts of Axin2::LacZ embryos at E14.5 either Wnt4+/+
or Wnt4/ (n = 5 or 4, respectively). Arrows mark mammary buds. Scale
bar: 5 mm.
B Whole-mount analysis of X-gal- and carmine alum-stained mammary
glands harvested from 6-week-old littermates either Wnt4fl/wt;MMTV::Cre+;
Axin2+/lacZ (n = 5) or Wnt4fl/fl MMTV::Cre+;Axin2+/lacZ (n = 4). Left insets:
higher magnification; right insets: histological section of the same gland.
Note expression of reporter detected around the neck of TEBs in Wnt4-
deficient and littermate control is comparable. LN, lymph node. Scale bars:
1 mm, and inset scale bar: 100 lm.
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allele in the present work. The ability of Wnt4/ epithelium to
form alveoli, which was preserved in previous transplants (Brisken
et al, 2000), was also observed upon serial transplantation when
mice were impregnated in this study.
Our finding that RANKL is not important for stem cell potential
is in apparent contradiction with previous results based on assays
with dissociated cells (Asselin-Labat et al, 2010). Compared to the
widely used single-cell-based assays in which a defined number of
cells are injected, grafting of intact epithelial fragments does not
allow one to determine the number or fraction of cells endowed
with regenerative potential. The approach does not disentangle the
role of different types of stem and progenitor cells and their rela-
tive contributions to the outgrowth cannot be defined. Yet, the
method is robust and multiple repeats of the experiment combined
with several rounds of transplantation give a semiquantitative
appreciation of an intact regeneration potential in a physiological
tissue context that is missed by the use of dissociated cells. In
fact, to our knowledge, this is currently the only stem cell assay
in which at least part of the microenvironment remains intact that
is so important to stem cell function. When single cells are
injected into a cleared fat pad, they need to survive and to adhere
to the stroma, an environment they are not exposed to physiologi-
cally. Both of these biological activities require integrin signaling
and control each other through direct cadherin-mediated cell–cell
contacts. In the widely used FACS-based stem cell assays,
mammary stem cells are selected for high expression of integrin
b1 or a6 (Shackleton et al, 2006; Stingl et al, 2006). It is conceiv-
able that the selected cells are not intrinsically better ‘stem cells’
A
B C
Figure 6. Models of hormonal stem cell control and Wnt4 action during mammary gland development.
A Control of mammary stem cell activity by Wnt4 during development. Schematic representation of mammary gland development (bottom) and control of mammary
stem/progenitor cells by hormones (top). Model showing Wnt4 expression during mammary gland development. Wnt4 is important for stem cell activation
throughout postnatal mammary gland development. Perinatal Wnt4 expression is independent of ER and PR, yet unknown factors control it. PR signaling is required
for Wnt4 expression in puberty and adulthood. PR expression is induced by ER signaling.
B Model of Wnt4 action in the mammary epithelium. Progesterone stimulation results in Wnt4 induction in the PR+ luminal cells (LC), the ‘sensor cells.’ The secreted
Wnt4 acts on adjacent basal/myoepithelial cells (MC). In the myoepithelial cells, Wnt4 activates canonical Wnt signaling which induces changes in gene expression.
This results in the secretion of factors and changes in the ECM (light blue arrows) that in turn impinge on stem cells (SC), luminal-restricted stem cells (L-RSC), and
basal-restricted stem cells (B-RSC). Wnt4 may also act directly on stem cells that are found within the basal layer.
C Model for the tumorigenic effects of progesterone and Wnt4 in the mammary epithelium. Repeated activation of this intercellular signaling cascade downstream
of PR signaling may promote tumorigenesis by expanding luminal progenitor cells with oncogenic mutations and by expanding the stem/progenitor cell
compartment.
Data information: In (B, C), black: basal lamina, F: fibroblast, LC: luminal cell.
ª 2015 The Authors The EMBO Journal Vol 34 | No 5 | 2015
Renuga Devi Rajaram et al Progesterone/Wnt4 control of mammary stem cells The EMBO Journal
649
Published online: January 20, 2015 
but that they have a strong advantage in adhering and surviving
in the cleared fat pad, which is a conditio sine qua non for giving
rise to de novo ducts. Alternatively, RANKL may be specifically
required for the bipotential stem cells that are revealed under the
challenging conditions of the single cell grafts. In the serial trans-
plant approach, which is based on intact pieces of mammary
tissue, the luminal- and the basal-restricted stem cells likely
account for most of the cellular proliferation during development
and a role of RANKL for the bipotent progenitors may not be
discerned.
Our finding that Wnt4 secreted by PR+ luminal cells activates
canonical Wnt signaling exclusively in the neighboring basal/p63+
cells, points to a scenario, in which the myoepithelial/basal cells are
a central component of the microenvironment or ‘niche’ that
controls different types of stem cells (Fig 6B). The myoepithelial/
basal cells are ultimately under control of progesterone and Wnt4;
hence, stem cell activity controlled through the microenvironment/
niche is linked to reproductive needs. Whether the rare bipotent
mammary stem cells that are found in the basal layer (Wang et al,
2014) are directly and/or indirectly activated by Wnt4 is not
addressed by our experiments but will be an exciting line of future
work.
The finding that the myoepithelial/basal cells are the prime
target of Wnt4 bears on a long-standing conundrum. Wnt1 was
long identified as an oncogene in the mouse mammary gland,
and Wnt signaling is key for the development of the mammary
gland. Yet, mutations in intracellular Wnt signaling components
have not been found in breast carcinomas, which are of luminal
origin. It is conceivable that Wnt signaling activation in the
myoepithelial cells indirectly promotes tumorigenesis by inducing
gene expression changes that result in the secretion of stimula-
tory signals and/or modulation of the extracellular matrix that
result in the activation of luminal progenitor cells. Luminal
progenitors with acquired oncogenic mutations could be
expanded in response to Wnt4 stimulation of the myoepithelium
(Fig 6C). In parallel, Wnt4, through its direct and/or indirect
action on bipotent mammary stem cells, increases the number of
stem cells. This in turn may result in an increased pool of lumi-
nal progenitors, which are more prone to oncogenic insults than
more differentiated luminal cells.
These findings have clinical implications. The activation of the
progesterone/Wnt4 pathway, which also operates in the human
breast (Tanos et al, 2013; Pardo et al, 2014), may underlie the
tumor promoting effects of recurrent menstrual cycles, oral contra-
ception, and combined hormone replacement therapy with proges-
tins. Selective progesterone receptor modulators and Wnt inhibitors,
alone or together with RANKL inhibitors, may therefore be effective
in breast cancer management, in particular, as preventive strategy
in high-risk premenopausal women.
Materials and Methods
Animals
Axin2::LacZ (Lustig et al, 2002), C57BL/6-Tg(Act-EGFP) (Okabe
et al, 1997), ERa/ (Dupont et al, 2000), MMTV::Cre (line A)
(Wagner et al, 1997), mT/mG (Muzumdar et al, 2007), PR/ (Lydon
et al, 1995), RAG1/ (Mombaerts et al, 1992), RANKL/ (Wong
et al, 1999), Wnt4/ (Stark et al, 1994), Wnt4Cre (Shan et al, 2010),
and Wnt4fl/fl mice (Shan et al, 2009) were kept on mixed genetic
background 129SV/C57Bl6. All mice were maintained and handled
according to the Swiss guidelines for animal safety. The ethic veteri-
nary committee of canton of Vaud, Switzerland, approved all the
animal experiments (Permit ID 1641.2 and 1641.3). To stage the
estrus cycle, the vagina was flushed with 10 ll of PBS and vaginal
secretions were collected, spread onto glass slides, and analyzed for
different cell types (Caligioni, 2009). Mammary bud and mammary
epithelial transplantations from 8-week-old donors were performed
as described (Brisken et al, 2000). For serial transplantations,
EGFP+ mammary duct outgrowth was visualized by stereo epi-
fluorescensce. Tissue fragments were prepared and retransplanted
starting from at least three independent donors. Hormone treat-
ments and BrdU injections were performed as described in Beleut
et al (2010).
Mammary whole-mounts and image analysis
Mammary gland whole-mounting and (5-bromo-4-chloro-3-indolyl-
beta-D-galacto-pyranoside) X-gal staining were performed as
described (Brisken et al, 1998). Images were acquired either using
a LEICA MZ FLIII stereomicroscope with PixeLINK (PL-A662)
camera or LEICA M205FA/MZ16F fluorescent stereomicroscope
with Leica DFC 340FX or Leica DC300F camera. Area of the fat
pad filled by the mammary ducts was quantified by drawing a
contour around the mammary ductal tips using Axiovision Rel
4.7 software. TEBs and branching points were quantified on
images of whole-mounted mammary glands and on fluorescence
stereo micrographs.
Immunostaining
Mammary glands were fixed in 4% paraformaldyde for 2 h at
room temperature and embedded in paraffin. Five-micrometer
sections were used for nuclear red and for immunohistochemical
or immunofluorescence staining. Anti-p63 Molecular Probes 4A4
(1:100), anti-BrdU Oxford biotechnology, OBT0030, 1:300), anti-PR
Thermo Fisher Scientific Pierce-MA1-411 (1:500), anti-GFP Molecu-
lar Probes A11122 (1:800). Images were acquired on LEICA DM
2000 microscope with a PixeLINK (PL-A662) camera or on Zeiss
Axioplan 2-imaging fluorescence microscope with Axiocam MRm
camera.
RNA extraction and semiquantitative RT–PCR
Mammary glands were homogenized in TRIzol (Invitrogen). Total
RNA was isolated from fragments using RNeasy (Qiagen). cDNA
was synthesized using random p(dN)6 primers (Roche Diagnostics)
and MMLV reverse transcriptase (Invitrogen). Semiquantitative real-
time PCR analysis in triplicates was performed with SYBR Green
PCR Core Reagents system (Qiagen)/PerfeCTa SYBR Green Super-
Mix for iQTM (Quanta) on Realplex2 (Eppendorf) or 7900HT Fast
Real-Time PCR System (Applied Biosystems) qRT–PCR detection
systems. All reactions were performed in triplicate. The following
primers sequences were used: Wnt4, AGG AGT GCC AAT ACC AGT
TCC, TGT GAG AAG GCT ACG CCA TA; Axin-2, GGC AGT GAT
GGA GGA AAA TG, TGG GTG AGA GTT TGC ACT TG; CK18
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(Schroeder & Lee, 1998); 18S rRNA, GCA ATT ATT CCC CAT GAA
CG, GGC CTC ACT AAA CCA TCC AA.
Statistics
Two-tailed, paired Student’s t-test was used to calculate statistical
significance; data are shown as means  SD. Statistical analyses
were carried out using Microsoft Excel. For serial transplantation,
the extent of fat pad filling in percentage at each generation was
compared by Wilcoxon signed rank test between contralateral
outgrowths. The statistical software R was used for analysis. The
statistical test used and P-values are indicated in each figure legend.
P < 0.05 was considered to indicate statistical significance.
*P < 0.05, **P < 0.01, ***P < 0.001.
Supplementary information for this article is available online:
http://emboj.embopress.org
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